Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12

Diabetes

Volumn 45, Issue 11, 1996, Pages 1503-1510

  Byrne, Maria M ^a   Sturis, Jeppe ^a   Menzel, Stephan ^a   Yamagata, Kazuya ^a   Fajans, Stefan S ^b   Dronsfleld, Mark J ^c   Bain, Stephen C ^c   Hattersley, Andrew T ^d   Velho, Gilberto ^e   Froguel, Phillipe ^f   Bell, Graeme I ^a   Polonsky, Kenneth S ^a,g  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF EXETER   (United Kingdom)

^e SAINT LOUIS HOSPITAL   (France)

^f INSTITUT PASTEUR DE LILLE   (France)

^g UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHROMOSOME 12; DIABETES MELLITUS; GENE LOCATION; GENE MUTATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLYCOSYLATION; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; INSULIN RELEASE; NORMAL HUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 10244249309     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.11.1503     Document Type: Article

References (21)

1. Fajans SS: Scope and heterogeneous nature of MODY. Diabetes Care 13:49-64, 1990 (Erratum, 13:910,1990)
2. Fajans SS, Bell GI, Bowden DW, Halter JB, Polonsky KS: Maturity-onset diabetes of the young. Life Sci 55:413-422,1994
3. Bell GI, Xiang K, Newman MV, Wu S, Wright LG, Fajans SS, Spielman RS, Cox NJ: Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci USA 88:1484-1488,1991
4. Cox NJ, Xiang K, Fajans SS, Bell GI: Mapping diabetes-susceptibility genes: lessons learned from search for DNA marker for maturity-onset diabetes of the young. Diabetes 41:401-407,1992
5. Froguel P, Vaxillaire M, Sun F, Velho G, Zouali H, Butel MO, Lesage S, Vionnet N, Clément K, Fougerousse F, Tanizawa Y, Weissenbach J, Beckmann JS, Lathrop GM, Passa P, Permutt MA, Cohen D: Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature (London) 356:162-164, 1992 (Erratum, 357:607,1992)
6. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt MA, Beckmann JS, Bell GI, Cohen D: Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med 328:697-702, 1093
7. Vaxillaire M, Boccio V, Philippi A, Vigouroux C, Terwilliger J, Passa P, Beckmann JS, Velho G, Lathrop GM, Froguel P: A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nature Genet 9:418-423,1995
8. Menzel S, Yamagata K, Trabb JB, Nerup J, Permutt A, Fajans SS, Menzel R, Iwasaki N, Omori Y, Cox NJ, Bell GI: Localization of MODY3 to a 5 cM region of human chromosome 12. Diabetes 44:1408-1413,1995
9. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
10. Byrne MM, Sturis J, Clément K, Vionnet N, Pueyo ME, Stoffel M, Takeda J, Passa P, Cohen D, Bell GI, Velho G, Froguel P, Polonsky KS: Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest 93:1120-1130,1994
11. Byrne MM, Sturis J, Polonsky, KS: Insulin secretion and clearance during low-dose graded glucose infusion. Am J Physiol 268:E21-E27,1995
12. Morgan CR, Lazarow A: Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes 12:115-126,1963
13. Faber OK, Binder C, Markussen J, Heding LG, Naithani VK, Kuzuya H, Blix P, Horwitz DL, Rubenstein AH: Characterization of seven C-peptide antisera. Diabetes 27 (Suppl. 1):170-177,1978
14. Van Cauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377,1992
15. Eaton RP, Allen RC, Schade DS, Erickson KM, Standefer J: Prehepatic insulin production in man: peripheral analysis using connecting peptide behavior. J Clin Endocrinol Metab 51:520-528,1980
16. Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B: Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 77:98-105,1986
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419,1985
18. Byrne MM, Sturis J, Fajans SS, Javier Ortiz F, Stoltz A, Stoffel M, Smith MJ, Bell GI, Halter JB, Polonsky KS: Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes 44(6):699-704,1995
19. Byrne MM, Sturis J, Sobel RJ, Polonsky KS. Elevated plasma glucose 2-hour post challenge predicts defects in β-cell function. Endocrinol Metab 33:8572-8579,1996
20. Leahy JL, Bumbalo LM, Chen C: β-cell hypersensitivity for glucose precedes loss of glucose-induced insulin secretion in 90% pancreatectomized rats. Diabetologia 36:1238-1244,1993
21. Ward WK, Wallum BJ, Beard JC, Taborsky GJ Jr, Porte D Jr: Reduction of glycemic potentiation: sensitive indicator of β-cell loss in partially pancreatertomized dogs. Diabetes 37:723-729,1988